Impact of blood factors on endothelial cell metabolism and function in two diverse heart failure models
Open Access
- 13 February 2023
- journal article
- research article
- Published by Public Library of Science (PLoS) in PLOS ONE
- Vol. 18 (2) , e0281550
Abstract
Role of blood-based factors in development and progression of heart failure (HF) is poorly characterized. Blood contains factors released during pathophysiological states that may impact cellular function and provide mechanistic insights to HF management. We tested effects of blood from two distinct HF models on cardiac metabolism and identified possible cellular targets of the effects. Blood plasma was obtained from daunorubicin- and myocardial infarction-induced HF rabbits (Dauno-HF and MI-HF) and their controls (Dauno-Control and MI-Control). Effects of plasma on bioenergetics of myocardial tissue from healthy mice and cellular cardiac components were assessed using high-resolution respirometry and Seahorse flux analyzer. Since endothelial cell respiration was profoundly affected by HF plasma, effects of plasma on endothelial cell barrier function and death were further evaluated. Western-blotting and electron microscopy were performed to evaluate mitochondrial proteins and morphology. Brief exposure to HF plasma decreased cardiac tissue respiration. Endothelial cell respiration was most impacted by exposure to HF plasma. Endothelial cell monolayer integrity was decreased by incubation with Dauno-HF plasma. Apoptosis and necrosis were increased in cells incubated with Dauno-HF plasma for 24 h. Down-regulation of voltage-dependent anion-selective channel (VDAC)-1, translocase of outer membrane 20 (Tom20), and mitochondrial fission factor (MFF) in cells exposed to Dauno-HF plasma and mitochondrial signal transducer and activator of transcription 3 (Stat3) and MFF in cells exposed to MI-HF plasma were observed. Mitochondrial structure was disrupted in cells exposed to HF plasma. These findings indicate that endothelial cells and mitochondrial structure and function may be primary target where HF pathology manifests and accelerates. High-throughput blood-based screening of HF may provide innovative ways to advance disease diagnosis and management.Keywords
Funding Information
- National Heart, Lung, and Blood Institute (HL091071)
- National Institute on Aging (AG058174)
- National Heart, Lung, and Blood Institute (HL144299-01A1)
- National Institute of General Medical Sciences (P20GM103652)
- U.S. Department of Veterans Affairs (BX001963)
- U.S. Department of Veterans Affairs (BX005229)
- U.S. Department of Veterans Affairs (BX003774)
- Tobacco-Related Disease Research Program (T31IP1929)
This publication has 41 references indexed in Scilit:
- The role of VDAC in cell death: Friend or foe?Biochimica et Biophysica Acta (BBA) - Biomembranes, 2012
- Mff is an essential factor for mitochondrial recruitment of Drp1 during mitochondrial fission in mammalian cellsJournal of Cell Biology, 2010
- Mitochondria in heart failureCardiovascular Research, 2010
- Mitochondrial reserve capacity in endothelial cells: The impact of nitric oxide and reactive oxygen speciesFree Radical Biology and Medicine, 2010
- Mitochondrial Medicine and the Neurodegenerative MitochondriopathiesPharmaceuticals, 2009
- Function of Mitochondrial Stat3 in Cellular RespirationScience, 2009
- Endothelial adherens and tight junctions in vascular homeostasis, inflammation and angiogenesisBiochimica et Biophysica Acta (BBA) - Biomembranes, 2008
- Endothelial Cell Activation in Patients With Decompensated Heart FailureCirculation, 2005
- Serum From Patients With Acute Coronary Syndromes Displays a Proapoptotic Effect on Human Endothelial CellsCirculation, 2003
- The cardiac endothelium: Functional morphology, development, and physiologyProgress in Cardiovascular Diseases, 1996